Provided by Tiger Fintech (Singapore) Pte. Ltd.

Marker Therapeutics, Inc.

1.19
-0.0100-0.83%
Post-market: 1.17-0.0200-1.68%19:13 EDT
Volume:41.66K
Turnover:50.23K
Market Cap:12.74M
PE:-1.00
High:1.25
Open:1.20
Low:1.19
Close:1.20
Loading ...

Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference

GlobeNewswire
·
01 Apr

Marker Therapeutics (MRKR) Receives a Buy from Canaccord Genuity

TIPRANKS
·
01 Apr

Marker Therapeutics Price Target Maintained With a $12.50/Share by WBB Securities

Dow Jones
·
01 Apr

Marker Therapeutics FY Net Income USD -10.7 Million

THOMSON REUTERS
·
31 Mar

Press Release: Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results

Dow Jones
·
31 Mar

Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
21 Mar

Marker Therapeutics up 8% After Canaccord Genuity Initiates Coverage With "Buy" Rating

THOMSON REUTERS
·
06 Mar

Canaccord Genuity Initiates Marker Therapeutics at Buy With $8 Price Target

MT Newswires Live
·
05 Mar

Marker Therapeutics initiated with a Buy at Canaccord

TIPRANKS
·
05 Mar

Marker Therapeutics initiated with a Buy at Brookline

TIPRANKS
·
11 Feb

BRIEF-Marker Therapeutics Inc Files For Resale Of Up To 10.1 Million Shares By The Selling Stockholders - SEC Filing

Reuters
·
11 Jan

Marker Therapeutics Inc Files for Resale of up to 10.1 Mln Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
11 Jan

Marker Therapeutics to Raise $16.1 Million in Private Placement

MT Newswires Live
·
20 Dec 2024

BRIEF-Marker Therapeutics Provides A Clinical Update On MT-601 In Patients With Lymphoma

Reuters
·
19 Dec 2024

BUZZ-Marker Therapeutics slides after $16 mln private placement

Reuters
·
19 Dec 2024

Marker Therapeutics sells 5.03M shares at $3.20 in private placement

TIPRANKS
·
19 Dec 2024

Marker Therapeutics provides update on MT-601 patients

TIPRANKS
·
19 Dec 2024

Marker Therapeutics Announces $16.1 Million Private Placement

THOMSON REUTERS
·
19 Dec 2024

Marker Therapeutics Announces $16.1 Million Private Placement

GlobeNewswire
·
19 Dec 2024

Marker Therapeutics Provides a Clinical Update on Mt-601 in Patients With Lymphoma

THOMSON REUTERS
·
19 Dec 2024